Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 27 November 2024
Revised: 19 December 2024
Accepted: 26 December 2024
First Online: 3 February 2025
Competing interests
: B.K. declares no conflict of interest. J.M.K has served on advisory boards for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, EMD serrano, Gilead, GlaxoSmithKline, Aurinia Pharmaceuticals, Rome Therapeutics, and Ventus Therapeutics. J.E.G has served on advisory boards for Bristol-Myers Squibb, Eli Lilly, Janssen, Boehringer Ingelheim, UBC, Novartis, Almirall, Oruka Therapeutics, Takeda, and AbbVie.
